# Asian Phase I Study Of PF-03446962

> **NCT01337050** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 36 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** PF-03446962

## Key facts

- **NCT ID:** NCT01337050
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-12
- **Final completion:** 2014-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337050, "Asian Phase I Study Of PF-03446962". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01337050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*